|
|
|
|
Continuous downstream bioprocessing brings efficiency gains but also new risks around system complexity, buffer management, and contamination control. Three practical innovations are helping process engineers address these challenges and strengthen process control today.
|
|
|
|
|
Stainless steel infrastructure is limiting bioprocessing agility. Single-use technologies enable modular facility designs, faster tech transfers, and real-time process analytics, helping biomanufacturers reduce costs and accelerate time to market.
|
|
|
|
|
Facility space costs up to $1,000/sq ft and planning timelines stretch 18 months, making your adherent cell culture platform choice one of the highest-stakes decisions in vaccine manufacturing scale-up.
|
|
|
|
|
Single-use systems have transformed pharmaceutical manufacturing by streamlining operations and reducing contamination risks. Discover how to overcome issues like scalability and quality assurance with integrated strategies to maximize efficiency and minimize risk.
|
|
|
